お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は伝染病治療薬市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは伝染病治療薬の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の伝染病治療薬市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは伝染病治療薬のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に伝染病治療薬市場を分類しています。本研究に含まれる主な企業は：Novartis、Gilead、GSK、Roche、Merck、Boehringer Ingelheim、Eli Lilly、AstraZeneca、J & J、Teva、AbbVie、Bausch Health、Abbott、Sanofi、Sun Pharma、Endo、Apotex、Amneal Pharma、Torrent Pharma

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    HIV
    Influenza
    TB
    Malaria
    Hepatitis
    HPV

用途別の市場セグメント：
    Hospital
    Clinic
    Other

本レポートの詳細内容
世界の伝染病治療薬市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、伝染病治療薬タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の伝染病治療薬収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の伝染病治療薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、伝染病治療薬市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

伝染病治療薬のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：伝染病治療薬のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：伝染病治療薬の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章伝染病治療薬企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：伝染病治療薬の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：伝染病治療薬の主要企業の概要を提供し、製品の説明と仕様、伝染病治療薬の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

In this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites
Market Analysis and Insights: Global Communicable Diseases Therapeutics Market
The global Communicable Diseases Therapeutics market is projected to grow from US$ 46740 million in 2024 to US$ 68580 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period.
The Communicable Diseases Treatment market refers to the pharmaceuticals and treatments used for the management and control of infectious diseases that can be transmitted from person to person. This market includes antiviral drugs, antibiotics, vaccines, and other therapies. The Communicable Diseases Treatment market has experienced significant growth due to factors such as the increasing prevalence of infectious diseases, the emergence of new pathogens, and the need for effective treatment options. Key players in the market include pharmaceutical companies, biotechnology firms, and government healthcare agencies. Geographically, the market is diverse, with regions facing different communicable disease burdens. 
Report Covers:
This report presents an overview of global market for Communicable Diseases Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Communicable Diseases Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Communicable Diseases Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Communicable Diseases Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Communicable Diseases Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Communicable Diseases Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novartis, Gilead, GSK, Roche, Merck, Boehringer Ingelheim, Eli Lilly, AstraZeneca and J & J, etc.

Market Segmentation
By Company
    Novartis
    Gilead
    GSK
    Roche
    Merck
    Boehringer Ingelheim
    Eli Lilly
    AstraZeneca
    J & J
    Teva
    AbbVie
    Bausch Health
    Abbott
    Sanofi
    Sun Pharma
    Endo
    Apotex
    Amneal Pharma
    Torrent Pharma

Segment by Type
    HIV
    Influenza
    TB
    Malaria
    Hepatitis
    HPV

Segment by Application
    Hospital
    Clinic
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Communicable Diseases Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Communicable Diseases Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Communicable Diseases Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Communicable Diseases Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of HIV
    Table 3. Key Players of Influenza
    Table 4. Key Players of TB
    Table 5. Key Players of Malaria
    Table 6. Key Players of Hepatitis
    Table 7. Key Players of HPV
    Table 8. Global Communicable Diseases Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Communicable Diseases Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Communicable Diseases Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Communicable Diseases Therapeutics Market Share by Region (2019-2024)
    Table 12. Global Communicable Diseases Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Communicable Diseases Therapeutics Market Share by Region (2025-2030)
    Table 14. Communicable Diseases Therapeutics Market Trends
    Table 15. Communicable Diseases Therapeutics Market Drivers
    Table 16. Communicable Diseases Therapeutics Market Challenges
    Table 17. Communicable Diseases Therapeutics Market Restraints
    Table 18. Global Communicable Diseases Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Communicable Diseases Therapeutics Revenue Share by Players (2019-2024)
    Table 20. Global Top Communicable Diseases Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Communicable Diseases Therapeutics as of 2023)
    Table 21. Global Communicable Diseases Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Communicable Diseases Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Communicable Diseases Therapeutics, Headquarters and Area Served
    Table 24. Global Key Players of Communicable Diseases Therapeutics, Product and Application
    Table 25. Global Key Players of Communicable Diseases Therapeutics, Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Communicable Diseases Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Communicable Diseases Therapeutics Revenue Market Share by Type (2019-2024)
    Table 29. Global Communicable Diseases Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Communicable Diseases Therapeutics Revenue Market Share by Type (2025-2030)
    Table 31. Global Communicable Diseases Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Communicable Diseases Therapeutics Revenue Share by Application (2019-2024)
    Table 33. Global Communicable Diseases Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Communicable Diseases Therapeutics Revenue Share by Application (2025-2030)
    Table 35. North America Communicable Diseases Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Communicable Diseases Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Communicable Diseases Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Communicable Diseases Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Communicable Diseases Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Communicable Diseases Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Communicable Diseases Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Communicable Diseases Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Communicable Diseases Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Communicable Diseases Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Communicable Diseases Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Communicable Diseases Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Communicable Diseases Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Communicable Diseases Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Communicable Diseases Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Communicable Diseases Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Communicable Diseases Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Communicable Diseases Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Communicable Diseases Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Communicable Diseases Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Communicable Diseases Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Communicable Diseases Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Communicable Diseases Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Communicable Diseases Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Communicable Diseases Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 67. Novartis Company Details
    Table 68. Novartis Business Overview
    Table 69. Novartis Communicable Diseases Therapeutics Product
    Table 70. Novartis Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 71. Novartis Recent Developments
    Table 72. Gilead Company Details
    Table 73. Gilead Business Overview
    Table 74. Gilead Communicable Diseases Therapeutics Product
    Table 75. Gilead Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 76. Gilead Recent Developments
    Table 77. GSK Company Details
    Table 78. GSK Business Overview
    Table 79. GSK Communicable Diseases Therapeutics Product
    Table 80. GSK Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 81. GSK Recent Developments
    Table 82. Roche Company Details
    Table 83. Roche Business Overview
    Table 84. Roche Communicable Diseases Therapeutics Product
    Table 85. Roche Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 86. Roche Recent Developments
    Table 87. Merck Company Details
    Table 88. Merck Business Overview
    Table 89. Merck Communicable Diseases Therapeutics Product
    Table 90. Merck Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 91. Merck Recent Developments
    Table 92. Boehringer Ingelheim Company Details
    Table 93. Boehringer Ingelheim Business Overview
    Table 94. Boehringer Ingelheim Communicable Diseases Therapeutics Product
    Table 95. Boehringer Ingelheim Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 96. Boehringer Ingelheim Recent Developments
    Table 97. Eli Lilly Company Details
    Table 98. Eli Lilly Business Overview
    Table 99. Eli Lilly Communicable Diseases Therapeutics Product
    Table 100. Eli Lilly Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 101. Eli Lilly Recent Developments
    Table 102. AstraZeneca Company Details
    Table 103. AstraZeneca Business Overview
    Table 104. AstraZeneca Communicable Diseases Therapeutics Product
    Table 105. AstraZeneca Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 106. AstraZeneca Recent Developments
    Table 107. J & J Company Details
    Table 108. J & J Business Overview
    Table 109. J & J Communicable Diseases Therapeutics Product
    Table 110. J & J Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 111. J & J Recent Developments
    Table 112. Teva Company Details
    Table 113. Teva Business Overview
    Table 114. Teva Communicable Diseases Therapeutics Product
    Table 115. Teva Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 116. Teva Recent Developments
    Table 117. AbbVie Company Details
    Table 118. AbbVie Business Overview
    Table 119. AbbVie Communicable Diseases Therapeutics Product
    Table 120. AbbVie Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 121. AbbVie Recent Developments
    Table 122. Bausch Health Company Details
    Table 123. Bausch Health Business Overview
    Table 124. Bausch Health Communicable Diseases Therapeutics Product
    Table 125. Bausch Health Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 126. Bausch Health Recent Developments
    Table 127. Abbott Company Details
    Table 128. Abbott Business Overview
    Table 129. Abbott Communicable Diseases Therapeutics Product
    Table 130. Abbott Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 131. Abbott Recent Developments
    Table 132. Sanofi Company Details
    Table 133. Sanofi Business Overview
    Table 134. Sanofi Communicable Diseases Therapeutics Product
    Table 135. Sanofi Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 136. Sanofi Recent Developments
    Table 137. Sun Pharma Company Details
    Table 138. Sun Pharma Business Overview
    Table 139. Sun Pharma Communicable Diseases Therapeutics Product
    Table 140. Sun Pharma Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 141. Sun Pharma Recent Developments
    Table 142. Endo Company Details
    Table 143. Endo Business Overview
    Table 144. Endo Communicable Diseases Therapeutics Product
    Table 145. Endo Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 146. Endo Recent Developments
    Table 147. Apotex Company Details
    Table 148. Apotex Business Overview
    Table 149. Apotex Communicable Diseases Therapeutics Product
    Table 150. Apotex Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 151. Apotex Recent Developments
    Table 152. Amneal Pharma Company Details
    Table 153. Amneal Pharma Business Overview
    Table 154. Amneal Pharma Communicable Diseases Therapeutics Product
    Table 155. Amneal Pharma Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 156. Amneal Pharma Recent Developments
    Table 157. Torrent Pharma Company Details
    Table 158. Torrent Pharma Business Overview
    Table 159. Torrent Pharma Communicable Diseases Therapeutics Product
    Table 160. Torrent Pharma Revenue in Communicable Diseases Therapeutics Business (2019-2024) & (US$ Million)
    Table 161. Torrent Pharma Recent Developments
    Table 162. Research Programs/Design for This Report
    Table 163. Key Data Information from Secondary Sources
    Table 164. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Communicable Diseases Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Communicable Diseases Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. HIV Features
    Figure 4. Influenza Features
    Figure 5. TB Features
    Figure 6. Malaria Features
    Figure 7. Hepatitis Features
    Figure 8. HPV Features
    Figure 9. Global Communicable Diseases Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Communicable Diseases Therapeutics Market Share by Application: 2023 VS 2030
    Figure 11. Hospital Case Studies
    Figure 12. Clinic Case Studies
    Figure 13. Other Case Studies
    Figure 14. Communicable Diseases Therapeutics Report Years Considered
    Figure 15. Global Communicable Diseases Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Communicable Diseases Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Communicable Diseases Therapeutics Market Share by Region: 2023 VS 2030
    Figure 18. Global Communicable Diseases Therapeutics Market Share by Players in 2023
    Figure 19. Global Top Communicable Diseases Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Communicable Diseases Therapeutics as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Communicable Diseases Therapeutics Revenue in 2023
    Figure 21. North America Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Communicable Diseases Therapeutics Market Share by Type (2019-2030)
    Figure 23. North America Communicable Diseases Therapeutics Market Share by Application (2019-2030)
    Figure 24. North America Communicable Diseases Therapeutics Market Share by Country (2019-2030)
    Figure 25. United States Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Communicable Diseases Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Communicable Diseases Therapeutics Market Share by Type (2019-2030)
    Figure 29. Europe Communicable Diseases Therapeutics Market Share by Application (2019-2030)
    Figure 30. Europe Communicable Diseases Therapeutics Market Share by Country (2019-2030)
    Figure 31. Germany Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Communicable Diseases Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Communicable Diseases Therapeutics Market Share by Type (2019-2030)
    Figure 39. China Communicable Diseases Therapeutics Market Share by Application (2019-2030)
    Figure 40. Asia Communicable Diseases Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Communicable Diseases Therapeutics Market Share by Type (2019-2030)
    Figure 42. Asia Communicable Diseases Therapeutics Market Share by Application (2019-2030)
    Figure 43. Asia Communicable Diseases Therapeutics Market Share by Region (2019-2030)
    Figure 44. Japan Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Communicable Diseases Therapeutics Market Share by Country (2019-2030)
    Figure 54. Brazil Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Communicable Diseases Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Novartis Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 61. Gilead Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 62. GSK Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 63. Roche Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 64. Merck Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 65. Boehringer Ingelheim Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 66. Eli Lilly Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 67. AstraZeneca Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 68. J & J Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 69. Teva Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 70. AbbVie Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 71. Bausch Health Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 72. Abbott Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 73. Sanofi Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 74. Sun Pharma Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 75. Endo Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 76. Apotex Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 77. Amneal Pharma Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 78. Torrent Pharma Revenue Growth Rate in Communicable Diseases Therapeutics Business (2019-2024)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed